\-\ Texto\\:\\ \ \(0\)\
\-\ moderate\\ point\\ tenderness\\ over\\ the\\ head\\ of\\ the\\ left\\ second\\ metatarsal\\.\ \(0\)\
\-\ treatment\\ options\\ for\\ freiberg\\'s\\ infraction\\ vary\\ based\\ upon\\ the\\ level\\ of\\ collapse\\ and\\ include\\ support\\ with\\ padding\\ or\\ orthotics\\,\\ casting\\ \\(used\\ in\\ the\\ early\\ stages\\ to\\ decrease\\ the\\ tendency\\ of\\ the\\ distal\\ bone\\ to\\ collapse\\)\\,\\ and\\ steroid\\ injections\\.\ \(0\)\
\-\ this\\ patient\\ was\\ under\\ treatment\\ with\\ conservative\\ measures\\ as\\ of\\ this\\ writing\\.\ \(0\)\
\-\ three\\ views\\ of\\ the\\ left\\ foot\\ demonstrate\\ flattening\\ of\\ the\\ second\\ metatarsal\\ head\\ with\\ associated\\ subchondral\\ lucency\\ and\\ subchondral\\ sclerosis\\.\\ \\ the\\ remaining\\ bones\\,\\ joints\\,\\ and\\ soft\\ tissues\\ are\\ unremarkable\\.\ \(0\)\
\-\ freiberg\\'s\\ infraction\ \(1\)\
\-\ essentially\\ pathognomonic\\ findings\\ for\\ freiberg\\'s\\ infraction\\.\ \(0\)\
\-\ this\\ patient\\ is\\ a\\ 14\\-year\\-old\\ female\\ soccer\\ player\\ and\\ track\\ athlete\\ who\\ presents\\ with\\ a\\ 3\\ month\\ history\\ of\\ left\\ foot\\ pain\\,\\ especially\\ over\\ the\\ dorsal\\ and\\ plantar\\ surfaces\\ of\\ the\\ distal\\ aspects\\ of\\ the\\ first\\ through\\ third\\ metatarsals\\.\ \(0\)\
\-\ please\\ see\\ the\\ accompanying\\ factoid\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ freiberg\\:\\ 0\\.12487346880434487\ \(0\)\
\-\ infraction\\:\\ 0\\.12487346880434487\ \(0\)\
\-\ metatarsal\\:\\ 0\\.059177918991109274\ \(0\)\
\-\ subchondral\\:\\ 0\\.056412390989687644\ \(0\)\
\-\ collapse\\:\\ 0\\.0550046184588199\ \(0\)\
\-\ padding\\:\\ 0\\.05108409587048147\ \(0\)\
\-\ 14\\-year\\-old\\:\\ 0\\.046724679640544706\ \(0\)\
\-\ orthotics\\:\\ 0\\.04532126107882011\ \(0\)\
\-\ foot\\:\\ 0\\.04443163138652214\ \(0\)\
\-\ writing\\:\\ 0\\.04236526341060794\ \(0\)\
\-\ second\\:\\ 0\\.04128464069482991\ \(0\)\
\-\ tendency\\:\\ 0\\.04096184484888335\ \(0\)\
\-\ athlete\\:\\ 0\\.03931175513525133\ \(0\)\
\-\ player\\:\\ 0\\.03762456025100806\ \(0\)\
\-\ metatarsals\\:\\ 0\\.03762456025100806\ \(0\)\
\-\ soccer\\:\\ 0\\.036925027954717346\ \(0\)\
\-\ \\'s\\:\\ 0\\.03554804940315179\ \(0\)\
\-\ track\\:\\ 0\\.035199010057222\ \(0\)\
\-\ surfaces\\:\\ 0\\.034952338905314566\ \(0\)\
\-\ vary\\:\\ 0\\.03426555090553474\ \(0\)\
\-\ accompanying\\:\\ 0\\.03384610829862486\ \(0\)\
\-\ injections\\:\\ 0\\.03345289850628942\ \(0\)\
\-\ stages\\:\\ 0\\.032243012389009826\ \(0\)\
\-\ casting\\:\\ 0\\.03178816546083607\ \(0\)\
\-\ aspects\\:\\ 0\\.030966654879596676\ \(0\)\
\-\ plantar\\:\\ 0\\.030715049001523095\ \(0\)\
\-\ head\\:\\ 0\\.03048555107640121\ \(0\)\
\-\ essentially\\:\\ 0\\.030126834800197164\ \(0\)\
\-\ flattening\\:\\ 0\\.029287014720797647\ \(0\)\
\-\ distal\\:\\ 0\\.02922363004963556\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.029093482276352656\ \(0\)\
\-\ support\\:\\ 0\\.02881391144257383\ \(0\)\
\-\ steroid\\:\\ 0\\.028373920319259928\ \(0\)\
\-\ remaining\\:\\ 0\\.027962707996852056\ \(0\)\
\-\ over\\:\\ 0\\.027366573460880034\ \(0\)\
\-\ dorsal\\:\\ 0\\.02735603965604978\ \(0\)\
\-\ options\\:\\ 0\\.026113706477071896\ \(0\)\
\-\ lucency\\:\\ 0\\.024686599344306573\ \(0\)\
\-\ decrease\\:\\ 0\\.024592727330365213\ \(0\)\
\-\ joints\\:\\ 0\\.024592727330365213\ \(0\)\
\-\ please\\:\\ 0\\.023846779264907057\ \(0\)\
\-\ point\\:\\ 0\\.02348499408164802\ \(0\)\
\-\ under\\:\\ 0\\.02348499408164802\ \(0\)\
\-\ measures\\:\\ 0\\.022996623426113014\ \(0\)\
\-\ bones\\:\\ 0\\.02267944824606967\ \(0\)\
\-\ views\\:\\ 0\\.022152286787685573\ \(0\)\
\-\ especially\\:\\ 0\\.022120761367411708\ \(0\)\
\-\ tissues\\:\\ 0\\.022058180670221972\ \(0\)\
\-\ upon\\:\\ 0\\.0219654619171578\ \(0\)\
\-\ treatment\\:\\ 0\\.02175618817108034\ \(0\)\
\-\ third\\:\\ 0\\.02154997920849055\ \(0\)\
\-\ conservative\\:\\ 0\\.02146440906977496\ \(0\)\
\-\ moderate\\:\\ 0\\.021133316406344634\ \(0\)\
\-\ used\\:\\ 0\\.020617510421056365\ \(0\)\
\-\ based\\:\\ 0\\.020494907938785917\ \(0\)\
\-\ early\\:\\ 0\\.0196550878593864\ \(0\)\
\-\ sclerosis\\:\\ 0\\.019303869392618522\ \(0\)\
\-\ factoid\\:\\ 0\\.018839216940969416\ \(0\)\
\-\ this\\:\\ 0\\.018134664402153455\ \(0\)\
\-\ three\\:\\ 0\\.01811713351161579\ \(0\)\
\-\ left\\:\\ 0\\.018039722061753107\ \(0\)\
\-\ first\\:\\ 0\\.018034487011231774\ \(0\)\
\-\ unremarkable\\:\\ 0\\.01779287055774881\ \(0\)\
\-\ tenderness\\:\\ 0\\.016345360521268136\ \(0\)\
\-\ month\\:\\ 0\\.016123361891827732\ \(0\)\
\-\ see\\:\\ 0\\.016039101957413763\ \(0\)\
\-\ level\\:\\ 0\\.015489868098408377\ \(0\)\
\-\ through\\:\\ 0\\.015263880618999175\ \(0\)\
\-\ include\\:\\ 0\\.015076437031637024\ \(0\)\
\-\ who\\:\\ 0\\.014012379931708818\ \(0\)\
\-\ bone\\:\\ 0\\.013354935103521195\ \(0\)\
\-\ soft\\:\\ 0\\.013087589710651258\ \(0\)\
\-\ associated\\:\\ 0\\.012682154477406931\ \(0\)\
\-\ 3\\:\\ 0\\.012584751740292704\ \(0\)\
\-\ demonstrate\\:\\ 0\\.012367623530396483\ \(0\)\
\-\ findings\\:\\ 0\\.011439226011257608\ \(0\)\
\-\ the\\:\\ 0\\.011303400636145504\ \(0\)\
\-\ female\\:\\ 0\\.011048806738665621\ \(0\)\
\-\ presents\\:\\ 0\\.010978894940301421\ \(0\)\
\-\ patient\\:\\ 0\\.010774741269388528\ \(0\)\
\-\ for\\:\\ 0\\.009171171681040442\ \(0\)\
\-\ \\,\\:\\ 0\\.008512895142053062\ \(0\)\
\-\ as\\:\\ 0\\.008129418276063697\ \(0\)\
\-\ history\\:\\ 0\\.007422732941553984\ \(0\)\
\-\ are\\:\\ 0\\.007326250770626427\ \(0\)\
\-\ and\\:\\ 0\\.006792792669140318\ \(0\)\
\-\ of\\:\\ 0\\.006594554762150289\ \(0\)\
\-\ pain\\:\\ 0\\.006563573380696445\ \(0\)\
\-\ or\\:\\ 0\\.006298885213608224\ \(0\)\
\-\ was\\:\\ 0\\.006215581900715012\ \(0\)\
\-\ to\\:\\ 0\\.005371925892364607\ \(0\)\
\-\ a\\:\\ 0\\.0049886767524352366\ \(0\)\
\-\ \\(\\:\\ 0\\.004543155510967676\ \(0\)\
\-\ \\)\\:\\ 0\\.004487658440964183\ \(0\)\
\-\ is\\:\\ 0\\.003536419989841042\ \(0\)\
\-\ with\\:\\ 0\\.002943501285280245\ \(0\)\
\-\ in\\:\\ 0\\.002650297044907264\ \(0\)\
\-\ \\.\\:\\ 0\\.0015628726583737352\ \(0\)\
